The regulatory approval from Central Drugs Standard Control Organisation (Food and Drug Administration Bhavan, New Delhi) ensures that MyGlucoHealth strips meets Indian standards of quality, safety and efficacy.
MyGlucoHealth provides a quick and convenient way for persons with diabetes to measure and self-manage blood glucose levels, Entra Health Systems said.
MyGlucoHealth, using automated tools, sends reminders to encourage patients to test more frequently, as well as to notify family, caregivers and clinicians when testing results reach critical levels.
MyGlucoHealth gives patients direct control over their care and provides clear lines of communication with clinicians and caregivers.
Entra Health Systems CEO Richard Strobridge said that MyGlucoHealth offers a comprehensive solution to help over 40 million diabetics in India better manage their condition using a mobile phone and online services.
